by clearskymd | Sep 1, 2022 | Company News
The ClearSky Medical Diagnostics team will be attending the International Parkinson and Movement Disorder Society (MDS) Congress in Spain this September. After two years of virtual events, the 2022 MDS Congress returns as a hybrid event – taking place virtually...
by clearskymd | Jun 10, 2022 | Company News
ClearSky’s co-founder Professor Stephen Smith discusses disruptive healthcare technologies in neurodegenerative diseases in the latest SCOR Innovation Podcast. The SCOR Innovation Podcast channel sheds light on evolving consumer needs in Life & Health...
by clearskymd | Apr 13, 2022 | Company News
ClearSky Medical Diagnostics recently attended and exhibited at the 35th Global Conference of Alzheimer’s Disease International in June 2022. The hybrid conference, hosted online and in-person at The Kia Oval in London, took place from 9 to 11 June 2022 with the...
by clearskymd | Mar 24, 2022 | Company News
ClearSky Medical Diagnostics has developed an intelligent medical device that can objectively diagnose mild cognitive impairment (MCI), a condition often suggested as an early stage of dementia. It is estimated that between five and 20 per cent of people aged over 65...
by clearskymd | Jan 11, 2022 | Company News
ClearSky Medical Diagnostics is supporting a new initiative to better understand the development of children’s brains during their early stages of life. The Wellcome Leap Program’s The First 1000 Days – Promoting Healthy Brain Networks project focuses on the...
by clearskymd | Dec 8, 2021 | Company News
ClearSky Medical Diagnostics and Shanghai Accurature Diagnostics Co Ltd have entered into a strategic cooperation agreement related to PD-Monitor. PD-Monitor is a medical device using ClearSky’s proprietary AI technology to assist the diagnosis and measurements of...
Recent Comments